NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
White Paper
May 7, 2010
After a stellar rise in Q4 2009, the total value of drug licensing agreements has taken a nosedive in
Q1 2010. The quarter has seen 133 agreements valued at USD 8.4bn, a staggering decrease of 52% by value from Q4 2009, in which 146 agreements with a total value of USD 17.4bn were announced.
Download to find out more.